Antibiotic Resistance in Poultry: A Comprehensive Review of Bacterial Pathogens

Introduction

Antibiotic resistance (ABR) in poultry bacterial pathogens represents a critical threat to both veterinary medicine and food safety. The intensive production systems common in modern poultry farming have historically relied on subtherapeutic and therapeutic antimicrobial use for growth promotion, prophylaxis, and disease treatment. This selective pressure has driven the emergence and dissemination of resistant bacterial strains within poultry flocks, with downstream consequences for transmission to humans through the food chain and environmental contamination [1]. The mechanisms underlying resistance are diverse and include target modification, enzymatic inactivation, efflux pump overexpression, and permeability changes. Horizontal gene transfer (HGT) via plasmids, transposons, and integrons accelerates the spread of resistance determinants among bacterial populations [2]. This review examines the principal bacterial pathogens affecting poultry, their resistance profiles, the molecular mechanisms involved, diagnostic approaches for resistance detection, and strategies for mitigation. The focus remains strictly on avian hosts and the veterinary perspective, with reference to relevant zoonotic implications only where direct host-range parallels apply.

Major Bacterial Pathogens and Their Resistance Profiles

Campylobacter Species

Campylobacter jejuni and Campylobacter coli are leading causes of bacterial gastroenteritis in humans and are frequently carried asymptomatically in poultry intestinal tracts. Resistance to fluoroquinolones (e.g., ciprofloxacin) emerged rapidly following the introduction of enrofloxacin use in poultry. The primary mechanism involves point mutations in the DNA gyrase gene gyrA, particularly at codon Thr-86-Ile, which reduces fluoroquinolone binding affinity [3]. Additionally, macrolide resistance (e.g., erythromycin) occurs through mutations in the 23S rRNA gene (A2075G or A2074C) or in ribosomal proteins L4 and L22. Campylobacter also exhibits multidrug resistance (MDR) phenotypes associated with the CmeABC efflux pump, a resistance-nodulation-division (RND) transporter that extrudes a broad range of antimicrobials including fluoroquinolones, macrolides, and tetracyclines [3]. Resistance to tetracyclines is mediated by the tet(O) gene, which encodes a ribosomal protection protein.

Salmonella enterica

Salmonella enterica serovars such as Typhimurium and Enteritidis are prevalent in poultry. Resistance profiles vary by serovar and geographic region. A key concern is the emergence of extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing strains. ESBL genes (e.g., blaCTX-M, blaSHV, blaTEM) are often plasmid-borne and confer resistance to third-generation cephalosporins such as ceftiofur, a veterinary cephalosporin [4]. Carbapenem resistance remains rare but has been detected in some poultry isolates, raising alarm. Fluoroquinolone resistance in Salmonella is primarily mediated by mutations in gyrA and parC (topoisomerase IV), often accompanied by increased expression of the AcrAB-TolC efflux pump. Many isolates carry class 1 integrons containing gene cassettes for aminoglycosides, trimethoprim, and sulfonamides. The co-selection of resistance genes through heavy metal tolerance (e.g., mercury, copper) on the same plasmids further complicates control [4].

Avian Pathogenic Escherichia coli (APEC)

Avian Pathogenic Escherichia coli (APEC) is the causative agent of colibacillosis, a major cause of morbidity and mortality in poultry flocks. APEC strains are characterized by a high prevalence of MDR. Resistance to fluoroquinolones is widespread and mediated by chromosomal mutations in gyrA and parC, as well as plasmid-mediated quinolone resistance (PMQR) genes such as qnrS, aac(6')-Ib-cr, and oqxAB [5]. ESBL and AmpC production, particularly through blaCTX-M-1 and blaCMY-2, is increasingly reported. In addition, APEC often harbors multiple plasmid replicon types (IncF, IncI1, IncN) that carry resistance determinants along with virulence genes, facilitating the co-dissemination of pathogenicity and resistance [5]. The closely related organism avian colibacillosis is reviewed in detail in the dedicated article on avian colibacillosis diagnosis and antimicrobial resistance trends. For further information on APEC virulence factors and pathotyping, refer to the comprehensive article on Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies.

Clostridium perfringens

Clostridium perfringens type A and type C are associated with necrotic enteritis in broilers. Antimicrobial resistance in C. perfringens has been documented for tetracyclines (tetA, tetB), macrolides (ermB, mefA), and lincosamides. Resistance to bacitracin, a commonly used feed additive, can occur through mutations in the bcrR locus and the presence of the bcrA gene encoding a transporter efflux pump [6]. The increasing reliance on in-feed antibiotics to control necrotic enteritis has contributed to the selection of resistant strains. For detailed discussion of pathogenesis and alternative control strategies, see the articles on Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies and Clostridium perfringens Type A in Broilers: Necrotic Enteritis Diagnosis and Alternatives to Antibiotics.

Mycoplasma gallisepticum

Mycoplasma gallisepticum causes chronic respiratory disease in poultry. Due to the lack of a cell wall, beta-lactams are ineffective. Macrolides and tetracyclines are the mainstays of therapy. Resistance to tylosin and tilmicosin has been reported and is associated with mutations in the 23S rRNA gene and in ribosomal proteins L4 and L22 [7]. Enrofloxacin resistance has also emerged. Molecular detection of resistance is challenging due to the fastidious nature of Mycoplasma, but PCR-based sequencing of target genes can identify point mutations. For a focused review, see Mycoplasma gallisepticum in Backyard Poultry: Clinical Presentation and Molecular Diagnostic Approaches.

Pasteurella multocida and Other Respiratory Pathogens

Pasteurella multocida, a causative agent of fowl cholera, is generally susceptible to many antibiotics, but resistance to sulfonamides, tetracyclines, and penicillins has been observed. Beta-lactamase production (blaROB-1) mediates ampicillin resistance. Gallibacterium anatis and Ornithobacterium rhinotracheale are emerging respiratory pathogens with increasing resistance to tetracyclines and macrolides. Limited data exist on the molecular mechanisms, but plasmid-mediated resistance is suspected [8].

Mechanisms of Antibiotic Resistance in Poultry Bacteria

Target Modification

Mutations in genes encoding drug targets represent a common resistance mechanism. In fluoroquinolone resistance, alterations in DNA gyrase (gyrA) and topoisomerase IV (parC) reduce drug binding. Macrolide resistance in Campylobacter and Mycoplasma arises from methylation of the 23S rRNA binding site by Erm methyltransferases or by point mutations. Beta-lactam resistance due to altered penicillin-binding proteins (PBPs) occurs in some Gram-positive isolates but is less common in Gram-negative poultry pathogens.

Enzymatic Inactivation

Enzymatic degradation or modification of antibiotics is widespread. Beta-lactamases hydrolyze the beta-lactam ring of penicillins and cephalosporins. ESBLs and AmpC enzymes are particularly important in Gram-negative enteric bacteria. Aminoglycoside-modifying enzymes (acetyltransferases, phosphotransferases, nucleotidyltransferases) confer resistance to gentamicin, kanamycin, and streptomycin. Chloramphenicol acetyltransferases inactivate this drug, though its use in poultry is banned in many countries.

Efflux Pumps

Efflux pumps can export multiple drug classes, contributing to MDR. The RND family pumps (e.g., AcrAB-TolC in Salmonella and E. coli, CmeABC in Campylobacter) are constitutively expressed or upregulated upon exposure. Overexpression is often controlled by local regulators (e.g., AcrR) or global regulators (e.g., MarA, SoxS). Efflux pump inhibitors have been investigated experimentally but are not yet in clinical veterinary use.

Horizontal Gene Transfer

HGT is a dominant force in the spread of resistance. Plasmids, transposons, and integrons facilitate the acquisition of resistance genes. Class 1 integrons, found in many Gram-negative poultry pathogens, capture gene cassettes via site-specific recombination. Conjugative plasmids (e.g., IncF, IncI1) can transfer multiple resistance determinants across bacterial strains and species. The presence of resistance genes on mobile genetic elements together with virulence factors is a particular concern in APEC, as it enables the simultaneous spread of pathogenicity and antibiotic resistance [5].

Diagnostic Approaches for Resistance Detection

Phenotypic antimicrobial susceptibility testing (AST) remains the reference standard. Disk diffusion and broth microdilution methods (including commercial panels) are used according to standards set by bodies such as the Clinical and Laboratory Standards Institute (CLSI). Minimum inhibitory concentration (MIC) breakpoints for veterinary pathogens are available for many drugs [9]. However, phenotypic AST is time-consuming and may not detect all resistance mechanisms, especially those requiring specific induction conditions.

Molecular diagnostics offer rapid detection of resistance genes. Conventional PCR, multiplex PCR, and real-time PCR assays are available for genes such as blaCTX-M, blaCMY-2, tet(O), qnrS, and ermB. High-throughput sequencing (whole genome sequencing, shotgun metagenomics) provides comprehensive resistance gene profiling, including detection of novel variants and mobile genetic elements [10]. However, the correlation between genotypic resistance and phenotypic expression is not absolute; silent or cryptic resistance genes may be present but not expressed, and novel mutations may not be captured by targeted assays.

The following table summarizes key poultry bacterial pathogens, their common resistance mechanisms, and recommended detection methods.

Clinical Implications of Antibiotic Resistance

The primary clinical consequence of ABR in poultry is treatment failure. In broiler flocks, colibacillosis and necrotic enteritis are common indications for antimicrobial therapy. When first-line drugs such as amoxicillin, enrofloxacin, or tetracyclines are no longer effective, practitioners must resort to higher-tier antibiotics, often with longer withdrawal periods and increased cost. This escalates the risk of residues and further resistance development [9].

Subtherapeutic antibiotic use for growth promotion has been banned in many jurisdictions, but therapeutic and metaphylactic use continues. The gut microbiome of poultry harbors a reservoir of resistance genes that can transfer to pathogens. For instance, commensal E. coli can act as a donor of ESBL plasmids to APEC strains. Moreover, resistance to heavy metals (e.g., copper, zinc) used as feed additives can co-select for antibiotic resistance due to co-resistance on the same genetic elements [4].

Mitigation Strategies and Antimicrobial Stewardship

Antimicrobial stewardship in poultry involves prudent use guidelines, including restriction of critically important antibiotics (e.g., fluoroquinolones, third-generation cephalosporins) to therapeutic use only after confirmed susceptibility. Alternatives such as vaccination, probiotics, prebiotics, organic acids, bacteriophages, and phytogenic feed additives are being explored to reduce antimicrobial reliance.

Vaccination: Vaccines against APEC, Salmonella, and necrotic enteritis (C. perfringens toxoid) are available and can reduce disease incidence and subsequent antimicrobial use. For example, live and killed Salmonella vaccines are used in layers and breeders.

Probiotics and Gut Health: Competitive exclusion products containing beneficial bacteria (e.g., Lactobacillus, Bifidobacterium) can inhibit pathogen colonization. Enzymes and organic acids (e.g., butyrate) modulate the gut environment and reduce the need for antibiotics.

Biosecurity: Improved biosecurity, all-in/all-out management, and litter management reduce pathogen load and the pressure to treat.

Integrated Diagnostic and Decision Workflow

The following Mermaid diagram outlines a decision workflow for managing suspected bacterial infections in poultry with a focus on antibiotic resistance considerations.

flowchart TD
    A[Clinical signs: mortality, lameness, respiratory distress, diarrhea], > B[Sample collection: cecal tonsils, liver, lung, pericardium]
    B, > C{Culture and isolation}
    C, >|Growth| D[Identification: MALDI-TOF or biochemical]
    C, >|No growth| E[Consider molecular testing: PCR for specific pathogens]
    D, > F[Antimicrobial susceptibility testing: disk diffusion / MIC]
    F, > G{Resistance profile determined?}
    G, >|Yes| H[Select narrow-spectrum antibiotic based on MIC]
    G, >|No| I[Empiric therapy with first-line drug per local guidelines]
    H, > J[Monitor treatment response and adjust if needed]
    I, > J
    F, > K[Resistance gene detection: PCR or sequencing for surveillance]
    K, > L[Update farm-level antibiogram]
    L, > M[Implement rotation or alternative control measures]
    E, > N[If PCR positive: consider targeted therapy or enhanced biosecurity]

This workflow emphasizes the importance of laboratory confirmation and susceptibility testing before antimicrobial use, when feasible. On-farm rapid tests are becoming available but are not yet comprehensive for resistance profiling.

Conclusion

Antibiotic resistance in poultry bacterial pathogens is a multifaceted problem driven by selective pressure from antimicrobial use and facilitated by horizontal gene transfer. Key pathogens such as Campylobacter, Salmonella, APEC, Clostridium perfringens, and Mycoplasma gallisepticum exhibit diverse resistance mechanisms including target mutations, enzymatic inactivation, and efflux. Surveillance through phenotypic and molecular diagnostics is essential for guiding therapy and monitoring trends. Antimicrobial stewardship, combined with vaccination, biosecurity, and alternatives to antibiotics, offers a sustainable path forward for poultry health. Continued research into resistance mechanisms and their ecological determinants will be critical for preserving the efficacy of existing antibiotics.

References

[1] World Health Organization. Antimicrobial resistance in zoonotic bacteria from food animals. WHO Document.

[2] Food and Agriculture Organization of the United Nations. Monitoring and surveillance of antimicrobial resistance in bacteria from healthy food animals. FAO Animal Production and Health Guidelines.

[3] Luangtongkum T, Jeon B, Han J, et al. Antibiotic resistance in Campylobacter: emergence, transmission, and persistence. Future Microbiology.

[4] Szmolka A, Nagy B. Multidrug resistant commensal Escherichia coli in animals and its impact for public health. Frontiers in Microbiology.

[5] Johnson TJ, Logue CM, Nolan LK. Avian pathogenic Escherichia coli: status of vaccine development. Avian Pathology.

[6] Keyburn AL, Bannam TL, Moore RJ, Rood JI. NetB, a pore-forming toxin from Clostridium perfringens type A, is associated with necrotic enteritis in chickens. Infection and Immunity.

[7] Waites KB, Talkington DF. Mycoplasma pneumoniae and its resistance to macrolides. Clinical Microbiology Reviews.

[8] Droual R. Antimicrobial resistance in Ornithobacterium rhinotracheale. Avian Diseases.

[9] Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. CLSI document VET01.

[10] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter on antimicrobial resistance.